- Opin vísindi
- →
- IRIS
- →
- IRIS
- →
- Skoða verk
JavaScript is disabled for your browser. Some features of this site may not work without it.
| Titill: | Geðrof í kjölfar ADHD-lyfjameðferðar : Sjúkratilfelli |
| Höfundur: |
|
| Útgáfa: | 2023-07-01 |
| Tungumál: | Íslenska |
| Umfang: | 4 |
| Deild: | Læknadeild Önnur svið Geðþjónusta |
| Birtist í: | Læknablaðið; 109(7-8) |
| ISSN: | 1670-4959 |
| DOI: | 10.17992/lbl.2023.0708.753 |
| Efnisorð: | Geðsjúkdómafræði; ADHD; methylphenidate; psychosis; ADHD; methylphenidate; psychosis; Young Adult; Central Nervous System Stimulants/adverse effects; Humans; Methylphenidate/adverse effects; Male; Psychotic Disorders/diagnosis; Iceland/epidemiology; Attention Deficit Disorder with Hyperactivity/diagnosis; Almenn læknisfræði |
| URI: | https://hdl.handle.net/20.500.11815/4395 |
Tilvitnun:Gudbrandsdottir , R K , Sigurðsson , E & Ingimarsson , O 2023 , ' Geðrof í kjölfar ADHD-lyfjameðferðar : Sjúkratilfelli ' , Læknablaðið , bind. 109 , nr. 7-8 , bls. 346-349 . https://doi.org/10.17992/lbl.2023.0708.753
|
|
Útdráttur:In view of the ongoing rise of ADHD prescriptions among adults in Iceland, it is important that doctors are aware that psychosis is a rare but at times a serious adverse reaction to such treatment. In 2022 5% of adults were prescribed medication to treat ADHD in Iceland. In this case report we present a case of methylphenidate-induced psychosis in a young man with no previous history of psychotic episodes who required admission to the psychiatric intensive care unit.
|
|
Athugasemdir:Publisher Copyright: © 2023 Laeknafelag Islands. All rights reserved.
|
|
